BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1667490)

  • 1. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
    Yang Y
    Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-myc gene without gene amplification in human hepatocellular carcinoma.
    Wu B; Wang M; You W; Yang S
    Chin Med J (Engl); 1996 Dec; 109(12):922-5. PubMed ID: 9275322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
    Naidu R; Wahab NA; Yadav M; Kutty MK
    Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of protooncogene bcl-2 in thyroid tumors].
    Zhu J; Chen Y; Xue H
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
    Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
    Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
    Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
    Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenes and growth factors in thyroid carcinogenesis.
    Frauman AG; Moses AC
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):479-93. PubMed ID: 2175702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
    Cerutti J; Trapasso F; Battaglia C; Zhang L; Martelli ML; Visconti R; Berlingieri MT; Fagin JA; Santoro M; Fusco A
    Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
    Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
    Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
    Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression.
    Greco C; Alvino S; Buglioni S; Assisi D; Lapenta R; Grassi A; Stigliano V; Mottolese M; Casale V
    Anticancer Res; 2001; 21(5):3185-92. PubMed ID: 11848471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergism of c-myc and p16 in oral squamous cell carcinoma].
    Liu NG; Shan CM; Wu SH; Lu ZH; Kang GY
    Ai Zheng; 2004 Jun; 23(6):635-9. PubMed ID: 15191661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E; Hiyama K; Yokoyama T
    Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Met expression in tall cell variant papillary carcinoma of the thyroid.
    Nardone HC; Ziober AF; LiVolsi VA; Mandel SJ; Baloch ZW; Weber RS; Mick R; Ziober BL
    Cancer; 2003 Oct; 98(7):1386-93. PubMed ID: 14508824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.